Yaping Mai

540 total citations
19 papers, 436 citations indexed

About

Yaping Mai is a scholar working on Molecular Biology, Immunology and Pharmaceutical Science. According to data from OpenAlex, Yaping Mai has authored 19 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Immunology and 6 papers in Pharmaceutical Science. Recurrent topics in Yaping Mai's work include Immunotherapy and Immune Responses (9 papers), RNA Interference and Gene Delivery (7 papers) and Drug Solubulity and Delivery Systems (4 papers). Yaping Mai is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), RNA Interference and Gene Delivery (7 papers) and Drug Solubulity and Delivery Systems (4 papers). Yaping Mai collaborates with scholars based in China. Yaping Mai's co-authors include Jianhong Yang, Yue Zhao, Shijie Ma, Yang Hou, Wannian Zhang, Qiang Liu, Qiang Liu, Xiaolong Li, Na Li and Qiang Liu and has published in prestigious journals such as ACS Applied Materials & Interfaces, Acta Biomaterialia and International Journal of Pharmaceutics.

In The Last Decade

Yaping Mai

19 papers receiving 431 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yaping Mai China 12 214 128 104 65 60 19 436
Patrick H. Demana South Africa 14 241 1.1× 121 0.9× 189 1.8× 81 1.2× 43 0.7× 38 585
Yueneng Yi China 7 150 0.7× 174 1.4× 107 1.0× 27 0.4× 36 0.6× 8 386
Jingyi Hong China 15 182 0.9× 192 1.5× 32 0.3× 81 1.2× 79 1.3× 31 644
Walter Kamm Germany 10 180 0.8× 73 0.6× 176 1.7× 83 1.3× 39 0.7× 15 391
Kantrol Kumar Sahu India 13 170 0.8× 62 0.5× 54 0.5× 65 1.0× 47 0.8× 28 349
Hongliang Wang China 14 222 1.0× 81 0.6× 88 0.8× 155 2.4× 122 2.0× 23 502
Rajeev Sharma India 14 305 1.4× 100 0.8× 188 1.8× 198 3.0× 99 1.6× 55 693
Basmah N. Aldosari Saudi Arabia 12 236 1.1× 64 0.5× 123 1.2× 95 1.5× 71 1.2× 42 559
Nishi Mody India 12 189 0.9× 92 0.7× 148 1.4× 167 2.6× 132 2.2× 22 521

Countries citing papers authored by Yaping Mai

Since Specialization
Citations

This map shows the geographic impact of Yaping Mai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaping Mai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaping Mai more than expected).

Fields of papers citing papers by Yaping Mai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yaping Mai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaping Mai. The network helps show where Yaping Mai may publish in the future.

Co-authorship network of co-authors of Yaping Mai

This figure shows the co-authorship network connecting the top 25 collaborators of Yaping Mai. A scholar is included among the top collaborators of Yaping Mai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yaping Mai. Yaping Mai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Li, Xiaolong, Lixin Ma, Shijie Ma, et al.. (2025). Synergistic anti-tumor effects of mRNA vaccine and PERK inhibitor combination in melanoma treatment. Colloids and Surfaces B Biointerfaces. 254. 114808–114808. 3 indexed citations
2.
Mai, Yaping, et al.. (2024). Autoantigenic Peptide and Immunomodulator Codelivery System for Rheumatoid Arthritis Treatment by Reestablishing Immune Tolerance. ACS Applied Materials & Interfaces. 16(16). 20119–20131. 8 indexed citations
3.
Meng, Tingting, et al.. (2024). The potential application of complement inhibitors-loaded nanosystem for autoimmune diseases via regulation immune balance. Journal of drug targeting. 32(5). 485–498. 2 indexed citations
4.
Ma, Shijie, et al.. (2023). Immunotherapeutic treatment of lung cancer and bone metastasis with a mPLA/mRNA tumor vaccine. Acta Biomaterialia. 169. 489–499. 26 indexed citations
5.
Yu, Xueting, et al.. (2023). Therapeutic potential of tolerance-based peptide vaccines in autoimmune diseases. International Immunopharmacology. 116. 109740–109740. 12 indexed citations
6.
Ma, Shijie, et al.. (2022). Combination of a cationic complexes loaded with mRNA and α-Galactose ceramide enhances antitumor immunity and affects the tumor immune microenvironment. International Immunopharmacology. 113(Pt A). 109254–109254. 6 indexed citations
7.
Li, Xiaolong, et al.. (2022). The main battlefield of mRNA vaccine – Tumor immune microenvironment. International Immunopharmacology. 113(Pt A). 109367–109367. 13 indexed citations
8.
Ma, Shijie, et al.. (2022). Enhanced Influenza Immunity by Nasal Mucosal Administration of the TPGS-Modified Liposomal Vaccine. AAPS PharmSciTech. 23(7). 272–272. 3 indexed citations
9.
Zhao, Yue, et al.. (2022). Nanocrystals with different stabilizers overcome the mucus and epithelial barriers for oral delivery of multicomponent Bufadienolides. International Journal of Pharmaceutics. 616. 121522–121522. 11 indexed citations
10.
Mai, Yaping, et al.. (2021). Nanocrystals for Improving Oral Bioavailability of Drugs: Intestinal Transport Mechanisms and Influencing Factors. AAPS PharmSciTech. 22(5). 179–179. 30 indexed citations
11.
Ma, Shijie, et al.. (2021). Multi-directionally evaluating the formation mechanism of 1,4-dihydropyridine drug nanosuspensions through experimental validation and computer-aided drug design. Drug Development and Industrial Pharmacy. 47(10). 1587–1597. 2 indexed citations
12.
Mai, Yaping, et al.. (2021). Improved transdermal permeability of tanshinone IIA from cataplasms by loading onto nanocrystals and porous silica. Pharmaceutical Development and Technology. 26(10). 1061–1072. 3 indexed citations
13.
Li, Na, et al.. (2020). Docetaxel-loaded D-α-tocopheryl polyethylene glycol-1000 succinate liposomes improve lung cancer chemotherapy and reverse multidrug resistance. Drug Delivery and Translational Research. 11(1). 131–141. 33 indexed citations
14.
Mai, Yaping, et al.. (2020). Intranasal delivery of cationic liposome-protamine complex mRNA vaccine elicits effective anti-tumor immunity. Cellular Immunology. 354. 104143–104143. 133 indexed citations
15.
Mai, Yaping, et al.. (2020). Preparation and characterisation of tetrandrine nanosuspensions andin vitroestimate antitumour activity on A549 lung cancer cell line. Journal of Microencapsulation. 37(5). 384–393. 11 indexed citations
16.
Zhao, Yue, et al.. (2020). Isoliquiritigenin Nanosuspension Enhances Cytostatic Effects in A549 Lung Cancer Cells. Planta Medica. 86(8). 538–547. 28 indexed citations
17.
Mai, Yaping, et al.. (2020). Mechanism and Improved Dissolution of Glycyrrhetinic Acid Solid Dispersion by Alkalizers. Pharmaceutics. 12(1). 82–82. 51 indexed citations
18.
Liu, Qiang, Yaping Mai, Yue Zhao, et al.. (2019). A wet-milling method for the preparation of cilnidipine nanosuspension with enhanced dissolution and oral bioavailability. Journal of Drug Delivery Science and Technology. 55. 101371–101371. 48 indexed citations
19.
Yu, Rui, Yaping Mai, Yue Zhao, et al.. (2018). Targeting strategies of liposomal subunit vaccine delivery systems to improve vaccine efficacy. Journal of drug targeting. 27(7). 780–789. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026